Search - tctmd.com

Displaying 1 - 9 of 9

Sort: Relevancy | Date

News Daily News

FDA Is Surveilling Heparin but Believes Defective Quality Unlikely

Yael L. Maxwell

December 06, 2019

News Features

Subtherapeutic Heparin: As Stories Multiply, Concerns Mount

Yael L. Maxwell

November 27, 2019

News Industry News

AstraZeneca Initiates Voluntary Nationwide Recall of One Lot of BRILINTA 90mg Professional Sample Bottles Due to Report of Another Medicine in One Bottle from That Lot

May 26, 2017

News Daily News

比伐卢定标签更新，警告 STEMI 患者 PCI 后的急性支架血栓事件，建议持续输液

Shelley Wood

April 18, 2016

News Daily News

Label Update for Bivalirudin Warns of Acute Stent Thrombosis With PCI for STEMI, Recommends Continued Infusion

Shelley Wood

April 18, 2016

News Daily News

La Actualización del Prospecto de Bivalirudina Advierte del Riesgo de Trombosis Aguda de Stent con PCI para el Manejo de STEMI y Recomienda la Infusión Continuada

Shelley Wood

April 18, 2016

News Daily News

FDA: Long-Term Clopidogrel Neither Ups, Nor Cuts Risk of Death in CVD Patients

Yael L. Maxwell

November 08, 2015

News Daily News

FDA: Long-Term Clopidogrel Neither Ups, Nor Cuts Risk of Death in CVD Patients

Yael L. Maxwell

November 08, 2015

News Daily News

FDA：长期氯吡格雷既不增加也不降低心血管病患者死亡风险

Yael L. Maxwell

November 08, 2015

Advertisement

FDA Is Surveilling Heparin but Believes Defective Quality Unlikely

Subtherapeutic Heparin: As Stories Multiply, Concerns Mount

AstraZeneca Initiates Voluntary Nationwide Recall of One Lot of BRILINTA 90mg Professional Sample Bottles Due to Report of Another Medicine in One Bottle from That Lot

比伐卢定标签更新，警告 STEMI 患者 PCI 后的急性支架血栓事件，建议持续输液

Label Update for Bivalirudin Warns of Acute Stent Thrombosis With PCI for STEMI, Recommends Continued Infusion

La Actualización del Prospecto de Bivalirudina Advierte del Riesgo de Trombosis Aguda de Stent con PCI para el Manejo de STEMI y Recomienda la Infusión Continuada

FDA: Long-Term Clopidogrel Neither Ups, Nor Cuts Risk of Death in CVD Patients

FDA: Long-Term Clopidogrel Neither Ups, Nor Cuts Risk of Death in CVD Patients

FDA：长期氯吡格雷既不增加也不降低心血管病患者死亡风险

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content